How forever chemicals target developing male brains — and what this means for their autism risk
Theories suggest this gender gap may be because male brains are more sensitive to changes during development, and girls might be better at hiding the signs or showing them in different ways.
Now, a new study published in the European Journal of Neuroscience has uncovered a shocking link between PFAS — also known as 'forever chemicals — and autism in men.
Scientists gave pregnant mice a type of short-chain PFAS called PFHxA — a chemical that's still widely used even though it's been restricted in some parts of the world.
The mothers were fed small doses, similar to what people might come across in their daily lives, and when their pups grew up, the male mice showed clear changes in behavior.
They were less active, more anxious and had trouble with memory, while the female mice didn't seem affected at all.
'Although these effects were mild, finding behavioral effects only in males was reminiscent of the many neurodevelopmental disorders that are male-biased,' Ania Majewska, a neuroscience professor at the University of Rochester, said in a press release.
'This finding suggests that the male brain might be more vulnerable to environmental insults during neurodevelopment.'
Until recently, PFHxA was considered a 'safer' replacement for older, more notorious forever chemicals that have been phased out.
But this study suggests we may have just swapped one problem for another — especially when it comes to protecting developing male brains.
'Finding that developmental exposure to PFHxA has long-term behavioral consequences in a mammalian model is concerning when considering short-chain PFAS are thought to be safer alternatives to the legacy PFAS that have been phased-out of production,' study lead author Elizabeth Plunk said.
'Understanding the impacts of PFHxA on the developing brain is critical when proposing regulations around this chemical. Hopefully, this is the first of many studies evaluating the neurotoxicity of PFHxA.'
The findings, while done on mice, suggest we need to take a closer scientific look at the link between forever chemicals and autism.
'This work points to the need for more research in short-chain PFAS. To our knowledge, PFHxA has not been evaluated for developmental neurobehavioral toxicity in a rodent model,' said Majewska. '
'Future studies should evaluate the cellular and molecular effects of PFHxA, including cell-type specific effects, in regions associated with motor, emotional/fear, and memory domains to elucidate mechanistic underpinnings.'
PFAS — synthetic substances that persist in the environment and human body — have been likened to 'slow poisons' that may increase the risk of certain cancers, fertility troubles, liver damage and developmental delays in children.
There are over 4,700 PFAS, which are used to make items resistant to water, grease and stains.
They can be found in food packaging, cookware, waterproof clothing, firefighting foam, certain personal care products and — most recently — beer.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Scientists May Have Found the Blueprint of the Human Body in the Ocean
Here's what you'll learn when you read this story: One major division of the kingdom Animalia is Cnidarians (animals built around a central point) and bilaterians (animals with bilateral symmetry), which includes us humans. A new study found that the sea anemone, a member of the Cnidarian phylum, uses bilaterian-like techniques to form its body. This suggests that these techniques likely evolved before these two phyla separated evolutionarily some 600 to 700 million years ago, though it can't be ruled out that these techniques evolved independently. Make a list of complex animals as distantly related to humans as possible, and sea anemones would likely be near the top of the list. Of course, one lives in the water and the other doesn't, but the differences are more biologically fundamental than that—sea anemones don't even have brains. So it's surprising that this species in the phylum Cnidarians (along with jellyfish, corals, and other sea creatures) contains an ancient blueprint for bilaterians, of which Homo sapiens are a card-carrying member. A new study by a team of scientists at the University of Vienne discovered that sea anemones, whose Cnidarian status means they grow radially around a central point (after all, what is the 'face' of a jellyfish), use a technique commonly associated with bilaterians, known as bone morphogenetic protein (BMP) shuttling, to build their bodies. This complicates the picture of exactly when this technique evolved or if it possibly evolved independently of bilaterians. The results of the study were published last month in the journal Science Advances.'Not all Bilateria use Chordin-mediated BMP shuttling, for example, frogs do, but fish don't, however, shuttling seems to pop up over and over again in very distantly related animals making it a good candidate for an ancestral patterning mechanism,' University of Vienna's David Mörsdorf, a lead author of the study, said in a press statement. 'The fact that not only bilaterians but also sea anemones use shuttling to shape their body axes, tells us that this mechanism is incredibly ancient.' To put it simply, BMPs are a kind of molecular messenger that signals to embryonic cells where they are in the body and what kind of tissue they should form. Local inhibition from an inhibitor named Chordin (which can also act as a shuttle) along with BMP shuttling creates gradients of BMP in the body. When these levels are their lowest, for example, the body knows to form the central nervous system. Moderate levels signal kidney development, and maximum levels signal the formation of the skin of the belly. This is how bilaterians form the body's layout from back to body. Mörsdorf and his colleagues found that Chordin also acts as a BMP shuttle—just as displayed in bilaterians like flies and frogs. Thi signals that this particular evolutionary trait likely developed before Cnidarians and bilaterians diverged. Seeing as these two phylums of the animal kingdom have vastly different biological structures, that divergence occurred long ago, likely 600 to 700 million years ago. 'We might never be able to exclude the possibility that bilaterians and bilaterally symmetric cnidarians evolved their bilateral body plans independently,' University of Vienna's Grigory Genikhovich, a senior author of the study, said in a press statement. 'However, if the last common ancestor of Cnidaria and Bilateria was a bilaterally symmetric animal, chances are that it used Chordin to shuttle BMPs to make its back-to-belly axis.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Yahoo
36 minutes ago
- Yahoo
Brain's Memory Center Never Stops Making Neurons, Study Confirms
Though it's now clear humans continue to grow new brain cells throughout their entire lives, debate persists over whether this applies to specific areas involved with memory. Previous studies have made the case for and against the existence of neurogenesis in hippocampus beyond childhood. A new study now offers some of the clearest evidence yet that this crucial memory-forming region does form fresh neurons well into adulthood. The study is the work of researchers from the Karolinska Institute and the Chalmers University of Technology in Sweden, and looks specifically at the dentate gyrus section of the hippocampus, the part of the brain that acts as a key control center for emotions, learning, and storing episodic memories. Related: "This gives us an important piece of the puzzle in understanding how the human brain works and changes during life," says molecular biologist Jonas Frisén. Confirmation that humans can form new neurons in the hippocampus through life (as several other animals can) would inform a whole host of other scientific investigations, from how adults learn new skills to what happens to the brain as it deteriorates in old age. The team used RNA analysis to identify functions of brain cells in samples collected from people up to age 78, finding that some neurons were geared to function as neural progenitor cells (NPCs), which generate new nerve cells. The researchers also found similarities between human NPCs and those in mice, pigs, and monkeys. Through a process of machine learning, the researchers could also group cells according to their development, from their initial 'blank slate' stem cell characterization to being an immature neuron in the process of dividing. The results address questions raised by earlier studies (including one from some of the same researchers), which determined that new neurons were present in the human brain without being able to confirm exactly how they'd got there. "We have now been able to identify these cells of origin, which confirms that there is an ongoing formation of neurons in the hippocampus of the adult brain," says Frisén. By studying such a wide range of ages, the researchers confirmed neurogenesis keeps happening in the hippocampus throughout our adult lives – albeit at a slower rate, generally speaking, as we get older. It's also important to note that the analysis revealed different rates of neurogenesis in different people. That might point to differences in brain plasticity that affect learning, personality, and disease risk, but that's something that future studies will need to look at. One hypothesis is that certain brain conditions might be affected by how quickly fresh new neurons can be produced – some of the subjects in this study had a history of psychiatric or neurological diseases – but again this wasn't something that the researchers looked at directly, so follow-up studies will be needed. "Our research may also have implications for the development of regenerative treatments that stimulate neurogenesis in neurodegenerative and psychiatric disorders," says Frisén. The research has been published in Science. Pomegranates Could Limit Risks From Controversial Sports Supplement OCD's Origins Might Not Lie in The Brain Like We Thought The News Cycle Is a Stress Monster. But There's a Healthy Way to Stay Informed.
Yahoo
an hour ago
- Yahoo
Terry Smith Blasts Novo, Coloplast in Danish Life Science Rebuke
(Bloomberg) -- Terry Smith slammed two of Denmark's largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they weighed on the equity fund run by the man often dubbed 'Britain's Warren Buffett.' Foreign Buyers Swoop on Cape Town Homes, Pricing Out Locals Trump's Gilded Design Style May Be Gaudy. But Don't Call it 'Rococo.' Are Tourists Ruining Europe? How Locals Are Pushing Back Massachusetts to Follow NYC in Making Landlords Pay Broker Fees In California, Pro-Housing 'Abundance' Fans Rewrite an Environmental Landmark Novo's 'ability to snatch defeat from the jaws of victory in respect of its leadership in weight loss drugs continues to be remarkable,' Smith wrote in his semiannual letter to shareholders. The fund manager also said he is waiting with 'increasingly thin patience' for Novo and medical device manufacturer Coloplast to announce replacements for their ousted chief executives. Smith's Fundsmith Equity Fund slipped 1.9% in the first six months of the year, a drop he said was 'almost all' caused by the holding in Novo. After its Ozempic diabetes treatment and sister drug Wegovy sparked the global obesity craze that made it Europe's most valuable company, Novo has recently struggled to convince investors it has the pipeline to fend off scores of emerging rivals. Eli Lilly & Co. has been gaining the upper hand in the US, where Novo has also struggled to prevent the proliferation of cheaper copycat weight-loss shots. 'Its inability to deal with the US legal and regulatory system's approach to its success would be interesting to observe from a safe distance,' Smith said. Novo is a top-10 holding in the Fundsmith portfolio, according to its website. Novo declined to comment on Smith's letter. Shares of the drugmaker are down almost 30% so far this year. Meanwhile Coloplast's shares have slumped 23% this year as it struggled to generate sufficient growth from acquisitions, including the $1.3 billion takeover of Kerecis hf, an Icelandic maker of fish-skin dressings to treat human wounds. 'Coloplast was a company whose revenue growth rate was metronomic,' Smith wrote. 'Probably not coincidentally, following two major acquisitions, it has encountered a series of operational failures.' Coloplast didn't immediately respond to a request for comment. Both Novo and Coloplast are controlled by foundations, a model favored by some Danish companies that Smith said he has seen as a strength. Now, he is growing frustrated with the pace of change as they prepare for new leadership. Novo's CEO Lars Fruergaard Jorgensen was ousted in May in a move that shocked investors. Kristian Villumsen, Coloplast's CEO, was pushed out in the same month, with the chairman saying the company failed to deliver. --With assistance from Leonard Kehnscherper. For Brazil's Criminals, Coffee Beans Are the Target SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too Sperm Freezing Is a New Hot Market for Startups Pistachios Are Everywhere Right Now, Not Just in Dubai Chocolate China's Homegrown Jewelry Superstar ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data